Statin Therapy

The NIH announced a trial it is funding has been stopped early because an interim analysis found daily statin use greatly prevented major adverse CV events in people living with HIV.

A deep learning model utilized unstructured electronic health record data to identify specific patient-, physician- and system-level reasons for statin nonuse among patients with diabetes, researchers reported.

In a short-term study, researchers found no effect of statin therapy on self-reported muscle injury or symptoms after moderate exercise, regardless of whether patients were symptomatic at baseline.

Among adults with an indication for statin therapy for primary prevention, there are marked disparities in statin use by race and ethnicity groups, with the lowest use rates among Black and Hispanic adults, cross-sectional data show.

Dietary supplements are big business in the United States and elsewhere, especially when it comes to products marketed to support CV health.

NEW ORLEANS — Among adults with CAD, a treat-to-target LDL strategy of 50 mg/dL to 70 mg/dL was noninferior to a high-intensity statin therapy for the 3-year composite of death, MI, stroke or coronary revascularization, researchers wrote.

NEW ORLEANS — In high-risk patients on statin therapy, residual inflammatory risk as assessed by high-sensitivity C-reactive protein better predicted CV events and death than residual cholesterol risk as assessed by LDL, data show.

Many patients at risk for CVD, particularly women, did not accept statin therapy recommended to them by their health care provider, data show.

NEW ORLEANS — In the CLEAR Outcomes trial, bempedoic acid reduced risk for major CV events by 13% compared with placebo, including a 23% lower risk for MI, among adults with a history of CVD or at high risk deemed statin intolerant.

Adults with type 2 diabetes who use statins have a lower risk for hip fracture than those who do not use statins, according to data published in Diabetes/Metabolism Research and Reviews.